Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.94
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.30 (3.797%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intellectual Property Update

6 Mar 2024 07:00

RNS Number : 7248F
MicroSalt PLC
06 March 2024
 

 

6 March 2024

MicroSalt plc

("MicroSalt" or the "Company")

 

Intellectual Property ("IP") Update

 

MicroSalt plc, (AIM: SALT) a company producing full-flavour, low-sodium salt for food manufacturers and consumers, is pleased to announce that it has received a Notice of Allowance from the United States Patent and Trademark Office for Patent Application No. 18/175,028.

 

The Patent Application entitled Low Sodium Salt Composition, concerns the production of MicroSalt, a low-sodium salt that adheres better to foods than a traditional salt (which is not adhered to a carrier particle).

 

Receipt of a Notice of Allowance indicates that the claims in the patent application are patentable. MicroSalt expect the patent will be granted upon completion of certain administrative matters in short course. Once granted, the patent is expected to expire in 2039.

 

This Notice of Allowance relates to one of the 14 pending patent applications described in the Company's admission document dated 27 January 2024. MicroSalt also has counterpart patent applications with claims directed to similar subject matter as the Patent Application 18/175,028 pending in countries including China, Chile, Australia, Brazil, Europe, Canada, Japan, Russia, Mexico, India and Hong Kong.

 

MicroSalt also owns a previously issued United States patent directed to its salt carrier product and production processes, and a United States provisional patent application directed to additional innovations.

 

Rick Guiney, CEO of Microsalt, said:

 

"This Notice of Allowance further strengthens our IP position in the global low sodium market whilst providing additional evidence of our thought leadership position in the battle to lower sodium consumption worldwide."

 

 For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:

 

MicroSalt plc

Via Flagstaff

Rick Guiney, CEO 

 

 

Zeus (Nominated Adviser and Broker)

David Foreman / James Edis (Investment Banking)

Dom King (Corporate Broking), Rupert Woolfenden (Sales)

 

+44 (0)20 3829 5000

Flagstaff PR (Financial IR/FPR)  

+44 (0)20 7129 1474

Tim Thompson / Alison Allfrey / Anna Probert

microsalt@flagstaffcomms.com

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

 

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVUORSRUORUR
Date   Source Headline
20th Jun 20237:00 amRNSInnovative Eyewear Licensing Agreement for Reebok
16th Jun 20237:00 amRNSSpace Florida Awards Grant to Guident and NOVELSAT
14th Jun 20237:00 amRNSGuident Secures New Patent
26th May 20237:00 amRNSFinal Results Year ended 31 December 2022
18th May 20237:00 amRNSMicroSalt Jack Stein appointed Brand Ambassador
17th May 20237:00 amRNSMicroSalt expands U.S. retail presence
4th May 20234:40 pmRNSNotification of Major Holdings
2nd May 20237:00 amRNSMicroSalt partners with large USA Retailer
27th Apr 20235:35 pmRNSNotification of Major Holdings
17th Apr 20237:00 amRNSPlacing to raise £2 Million (C.US $ 2.50M)
14th Apr 20238:00 amRNSInnovation Eyewear Hosts First Smart Eyewear Show
12th Apr 20238:00 amRNSPatent Filed for ChatGPT Enabled Smart Eyewear
11th Apr 20238:00 amRNSPortfolio Company Update Innovation Eyewear
22nd Mar 20237:00 amRNSMicroSalt Operational Update
17th Mar 20237:00 amRNSGuident Update
13th Mar 20237:00 amRNSH Mart Partners with MicroSalt
8th Mar 20234:39 pmRNSHolding(s) in Company
8th Mar 20233:59 pmRNSIssue of Equity and total voting rights
2nd Mar 20237:00 amRNSInnovative Eyewear Launches New Titanium Styles
27th Feb 20237:00 amRNSMicroSalt Expands Low Sodium Shakers Distribution
24th Feb 20237:00 amRNSNOVELSAT and Guident Partnership
21st Feb 20237:00 amRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSPlacing to raise £2.25 Million(C.US$2.7M)
17th Feb 20237:00 amRNSGuident Portfolio Company Update
7th Feb 20237:00 amRNSLaunch of Lucyd Lyte 2.0 Smart Eyewear
6th Feb 20237:00 amRNSUS Salt forms Strategic Partnership with MicroSalt
6th Feb 20237:00 amRNSInnovative Eyewear New Features for Vyrb App
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSGiant Food agrees to carry MicroSalt Shakers
24th Jan 20233:19 pmRNSConversion of outstanding loan amount in MicroSalt
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
29th Dec 20222:00 pmRNSPrice Monitoring Extension
29th Dec 20227:00 amRNSInnovative Eyewear Global Licensing Agreement
28th Dec 20227:00 amRNSInnovative Eyewear Inc Provides Year end Review
21st Dec 20227:00 amRNSHannaford Brothers Partners with MicroSalt
20th Dec 20227:00 amRNSMicroSalt wins award
19th Dec 20227:00 amRNSNOMAD and Broker appointed for MicroSalt AIM IPO
8th Dec 20227:00 amRNSChange in Accounting Reference Date
15th Nov 20227:00 amRNSExercise of Stock Options and Total Voting Rights
14th Nov 20227:00 amRNSGuident to provide Autonomous Shuttle Services
31st Oct 20225:46 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSAppointment to the Board of MicroSalt
27th Oct 20227:00 amRNSGuident Update
25th Oct 20227:00 amRNSCFO Update
13th Oct 20227:00 amRNSMicroSalt Partnership
11th Oct 20227:00 amRNSInnovative Eyewear Executive Appointments
3rd Oct 20227:00 amRNSLucyd - Global Licensing Agreement Nautica Brand
23rd Sep 20227:00 amRNSMicroSalt lower sodium salt-shakers launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.